Schedule 13D ownership disclosure

Black Diamond Therapeutics Inc

Security class unavailable · CUSIP: 09203E105

Event date: 2020-02-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
19.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-035786
Form type
SC 13D
Filer
Black Diamond Therapeutics, Inc.
CIK
CIK 1701541
Filed
Feb 13, 2020
Reporting period
Feb 03, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub